DCM
NVAX icon

Driehaus Capital Management’s Novavax NVAX Stock Holding History

Driehaus Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3,683
Closed -$618K – 612
2015
Q4 		$618K Buy
3,683
+1,207
+49% +$186K 0.02% 433
2015
Q3 		$350K Sell
2,476
-945
-28% -$212K 0.01% 463
2015
Q2 		$762K Buy
3,421
+694
+25% +$122K 0.03% 432
2015
Q1 		$451K Buy
+2,727
New +$443K 0.02% 460

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Driehaus Capital Management's NVAX Position: Q1 2016 in Review

Driehaus Capital Management sold out of Novavax (NVAX) in Q1 2016, closing a stake of 3,683 shares — an estimated $618K sold.

Driehaus Capital Management first reported a position in NVAX in Q1 2015 and held it in 4 quarters. The position peaked at $762K in Q2 2015. 175 funds tracked by Wall St. Rank hold NVAX as of Q1 2016.

  • Driehaus Capital Management reported no remaining Novavax position as of Q1 2016 after selling out during the quarter.
  • Driehaus Capital Management sold 3,683 Novavax shares in Q1 2016, an estimated $618K.
  • Driehaus Capital Management first reported a position in Novavax in Q1 2015 and held it in 4 quarters.
  • Driehaus Capital Management's Novavax position peaked at $762K in Q2 2015.
  • 175 funds tracked by Wall St. Rank held Novavax as of Q1 2016.

Based on Driehaus Capital Management's 13F filing for Q1 2016, filed 13 May 2016.